Suppr超能文献

与胶质母细胞瘤复发和生存相关的治疗、性别和种族特异性 microRNA 标志物、靶基因和网络。

Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.

机构信息

Department of Animal Sciences, University of Illinois, Urbana, IL 61801, USA.

出版信息

Cancer Genomics Proteomics. 2011 Jul-Aug;8(4):173-83.

Abstract

AIM

To identify and study targets of microRNA biomarkers of glioblastoma survival across events (death and recurrence) and phases (life expectancy or post-diagnostic) using functional and network analyses.

MATERIALS AND METHODS

microRNAs associated with glioblastoma survival within and across race, gender, recurrence, and therapy cohorts were identified using 253 individuals, 534 microRNAs, Cox survival model, cross-validation, discriminant analyses, and cross-study comparison.

RESULTS

All 45 microRNAs revealed as being associated with survival were confirmed in independent cancer studies and 25 in glioblastoma studies. Thirty-nine and six microRNAs (including hsa-miR-222) were associated with one and multiple glioblastoma survival indicators, respectively. Nineteen and 26 microRNAs exhibited cohort-dependent (including hsa-miR-10b with therapy and hsa-miR-486 with race) and independent associations with glioblastoma, respectively.

CONCLUSION

Sensory perception and G protein-coupled receptor processes were enriched among microRNA gene targets also associated with survival and network visualization highlighted their relations. These findings can help to improve prognostic tools and personalized treatments.

摘要

目的

使用功能和网络分析,确定并研究跨越事件(死亡和复发)和阶段(预期寿命或诊断后)的胶质母细胞瘤生存的 microRNA 生物标志物的靶点。

材料与方法

使用 253 名个体、534 个 microRNA、Cox 生存模型、交叉验证、判别分析和跨研究比较,鉴定与种族、性别、复发和治疗队列内及跨队列的胶质母细胞瘤生存相关的 microRNAs。

结果

所有与生存相关的 45 个 microRNAs均在独立的癌症研究中得到了证实,其中 25 个在胶质母细胞瘤研究中得到了证实。39 个和 6 个 microRNAs(包括 hsa-miR-222)分别与一个和多个胶质母细胞瘤生存指标相关。19 个和 26 个 microRNAs分别表现出与胶质母细胞瘤相关的队列依赖性(包括与治疗相关的 hsa-miR-10b 和与种族相关的 hsa-miR-486)和独立性。

结论

感觉感知和 G 蛋白偶联受体过程在与生存相关的 microRNA 基因靶点中富集,网络可视化突出了它们的关系。这些发现有助于改善预后工具和个性化治疗。

相似文献

3
Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
J Neurooncol. 2013 May;112(3):347-54. doi: 10.1007/s11060-013-1078-6. Epub 2013 Feb 19.
4
MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
Tumour Biol. 2017 Nov;39(11):1010428317726842. doi: 10.1177/1010428317726842.
5
Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.
PLoS One. 2013;8(3):e58608. doi: 10.1371/journal.pone.0058608. Epub 2013 Mar 12.
9
Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
PLoS One. 2017 Sep 20;12(9):e0184969. doi: 10.1371/journal.pone.0184969. eCollection 2017.
10
Serum microRNA profiling in patients with glioblastoma: a survival analysis.
Mol Cancer. 2017 Mar 11;16(1):59. doi: 10.1186/s12943-017-0628-5.

引用本文的文献

3
Efficient Bayesian Regularization for Graphical Model Selection.
Bayesian Anal. 2019 Jun;14(2):449-476. doi: 10.1214/17-ba1086. Epub 2018 Jul 11.
4
Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis.
Biomed Res Int. 2020 Sep 25;2020:4689689. doi: 10.1155/2020/4689689. eCollection 2020.
5
Lasting and Sex-Dependent Impact of Maternal Immune Activation on Molecular Pathways of the Amygdala.
Front Neurosci. 2020 Aug 11;14:774. doi: 10.3389/fnins.2020.00774. eCollection 2020.
8
Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
Exp Ther Med. 2019 Nov;18(5):3439-3449. doi: 10.3892/etm.2019.7975. Epub 2019 Sep 5.

本文引用的文献

1
MicroRNAs: Potential biomarkers in cancer.
Indian J Clin Biochem. 2010 Jan;25(1):4-14. doi: 10.1007/s12291-010-0008-z. Epub 2010 Feb 10.
2
A hybrid feature selection method for DNA microarray data.
Comput Biol Med. 2011 Apr;41(4):228-37. doi: 10.1016/j.compbiomed.2011.02.004. Epub 2011 Mar 3.
3
Investigation gene and microRNA expression in glioblastoma.
BMC Genomics. 2010 Dec 1;11 Suppl 3(Suppl 3):S16. doi: 10.1186/1471-2164-11-S3-S16.
4
MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
Clin Cancer Res. 2010 Aug 15;16(16):4289-97. doi: 10.1158/1078-0432.CCR-10-0207. Epub 2010 Jul 2.
5
miR-182 as a prognostic marker for glioma progression and patient survival.
Am J Pathol. 2010 Jul;177(1):29-38. doi: 10.2353/ajpath.2010.090812. Epub 2010 May 14.
6
Reprogramming of miRNA networks in cancer and leukemia.
Genome Res. 2010 May;20(5):589-99. doi: 10.1101/gr.098046.109.
7
Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways.
DNA Cell Biol. 2010 Sep;29(9):553-61. doi: 10.1089/dna.2009.0978.
9
Expression and significance of FXYD-3 protein in gastric adenocarcinoma.
Dis Markers. 2010;28(2):63-9. doi: 10.3233/DMA-2010-0669.
10
Development of the human cancer microRNA network.
Silence. 2010 Feb 2;1(1):6. doi: 10.1186/1758-907X-1-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验